Public Release: 

Abstract submission and registration opens for the WCLC 2015

International Association for the Study of Lung Cancer

DENVER - Abstract submission, registration and housing opens today for the 16th World Conference on Lung Cancer (WCLC). This takes place in Denver, CO, USA on September 6 - 9, 2015. The WCLC is the world's largest meeting dedicated to lung cancer and other thoracic malignancies. More than 9,000 delegates come from more than 100 countries to discuss the latest developments in thoracic malignancy research at the Colorado Convention Center. IASLC is proudly looking forward to a program covering a wide range of disciplines including more than 300 invited speakers and 4,000 scientific abstracts presented.

WCLC 2015 offers the opportunity to learn and discuss groundbreaking research and progress with world-renowned experts in the field of lung cancer. Attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses, allied health professionals, advocates and patients.

WCLC 2015 is inviting those in the lung cancer field for their submission of scientific abstracts. The committees will also accept submissions of abstracts on clinical trials in progress. Submitters of such abstracts are asked to submit their abstract under the most appropriate category. For more information on submitting abstracts please visit the Call for Abstracts page on

Important Dates:

January 14, 2015 Abstract Submission Opens

January 14, 2015 Registration and Housing Opens

April 15, 2015 Abstract Submission Deadline

June 26, 2015 Early Registration Deadline

July 24, 2015 Regular Registration Deadline

For more information on submitting abstracts and registration please visit



The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association's membership includes nearly 4,000 lung cancer specialists in 80 countries. IASLC members promote the study of etiology, epidemiology, prevention, diagnosis, treatment and all other aspects of lung cancer and thoracic malignancies. Membership is open to any physician, scientist, nurse or allied health professional interested in lung cancer, including patients, survivors, caregivers and advocates. To learn more about IASLC please visit

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.